Cardiovascular Burden Is High in Pediatric Lung Transplant Recipients

Nima Memaran1, Mareike Onnen1, Carsten Müller2

  • 1Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany.

Transplantation
|January 4, 2022
PubMed

Insights

Pediatric lung transplant recipients experience significant cardiovascular damage, including arteriosclerosis and atherosclerosis. Early detection and intervention targeting identified risk factors are crucial for improving long-term outcomes.

Area of Science:

  • Pediatric Cardiology
  • Transplantation Medicine
  • Vascular Biology

Background:

  • Cardiovascular morbidity is prevalent in adult lung transplant (LTx) recipients.
  • Subclinical cardiovascular damage in pediatric LTx recipients remains undescribed.
  • Early indicators include increased pulse wave velocity (PWV), intima-media thickness (IMT), and left ventricular mass index (LVMI).

Purpose of the Study:

  • To describe the prevalence and risk factors of subclinical cardiovascular damage in pediatric LTx recipients.
  • To assess early signs of arteriosclerosis, atherosclerosis, and left ventricular hypertrophy.

Main Methods:

  • Prospective longitudinal study of 47 pediatric LTx recipients.
  • Annual assessments over a mean follow-up of 2.2 years (144 observations).
  • Measurements included PWV, IMT, LVMI, blood pressure, and glomerular filtration rate.

Main Results:

  • At inclusion, 13% had increased PWV, 30% had increased IMT, and 33% had elevated LVMI.
  • Higher PWV associated with male sex, longer time post-LTx, higher diastolic blood pressure, and lower GFR.
  • Higher IMT associated with male sex and lower hemoglobin; diabetes associated with higher LVMI.

Conclusions:

  • Pediatric LTx recipients face a substantial and ongoing burden of subclinical cardiovascular damage.
  • Cardiovascular morbidity requires attention given improving long-term LTx survival.
  • Identified risk factors offer potential targets for therapeutic interventions.
Abstract